The global market for Circular RNA Sequencing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Circular RNA (circRNA) has a closed circular structure and is a hot spot of recent research. It exists in large quantities in the cytoplasm of eukaryotic cells, and is mainly produced by pre-mRNA through variable shear processing, and is not affected by RNA exonucleases. The expression is more stable and not easy to degrade. Recent studies have shown that circRNAs have important regulatory functions. For example, circRNAs can play a competitive endogenous RNA (ceRNA) mechanism. Because their molecules are rich in microRNA (miRNA) binding sites, they act as miRNA sponges in cells. Release the inhibitory effect of miRNA on its target gene and increase the expression level of target gene. Especially through the interaction with disease-associated miRNAs, studies have shown that circRNAs can affect the proliferation, invasion and metastasis, angiogenesis and apoptosis of cancer cells. In addition, circRNA also has the functions of regulating other types of RNA and regulating protein activity. These characteristics make circRNA have the potential to develop new diagnosis and treatment methods for diseases, and the research significance is great. The main application areas of circRNA sequencing include research on the pathogenesis of diseases such as tumors; changes in the regulation of gene expression during growth and development; other research directions concerned with the regulation of gene transcription and expression.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Circular RNA Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Circular RNA Sequencing by region & country, by Type, and by Application.
The Circular RNA Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circular RNA Sequencing.
Market Segmentation
By Company
Creative Biogene
Bio Basic Asia Pacific
LC Sciences
Eurofins
Illumina
CD Genomics
Arraystar
Guangzhou Kidio Biotechnology Co., Ltd.
Shanghai Bioegene
Yanzai Biotechnology (Shanghai) Co., Ltd
Digital Spectrum (Shanghai) Biotechnology Co., Ltd
Guangzhou Codon Gene Technology Co., Ltd
Shanghai Biotechnology Corporation
Beijing Abace Biology
BGI TechSolutions Co.,Ltd. (BGI-Tech)
Shanghai Cloudseq
Wuhan Benagen Technology Company Limited
Hangzhou Lianchuan Biological Information Co.,Ltd.
Segment by Type:
ecircRNA Sequencing
ciRNA Sequencing
ElciRNA Sequencing
Other
Segment by Application
Research & Academic Institutes
Pharma & Biotech Companies
CROs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Circular RNA Sequencing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Circular RNA Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Circular RNA Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Circular RNA Sequencing Product Introduction
1.2 Global Circular RNA Sequencing Market Size Forecast
1.3 Circular RNA Sequencing Market Trends & Drivers
1.3.1 Circular RNA Sequencing Industry Trends
1.3.2 Circular RNA Sequencing Market Drivers & Opportunity
1.3.3 Circular RNA Sequencing Market Challenges
1.3.4 Circular RNA Sequencing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Circular RNA Sequencing Players Revenue Ranking (2023)
2.2 Global Circular RNA Sequencing Revenue by Company (2019-2024)
2.3 Key Companies Circular RNA Sequencing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Circular RNA Sequencing Product Offered
2.5 Key Companies Time to Begin Mass Production of Circular RNA Sequencing
2.6 Circular RNA Sequencing Market Competitive Analysis
2.6.1 Circular RNA Sequencing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Circular RNA Sequencing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circular RNA Sequencing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 ecircRNA Sequencing
3.1.2 ciRNA Sequencing
3.1.3 ElciRNA Sequencing
3.1.4 Other
3.2 Global Circular RNA Sequencing Sales Value by Type
3.2.1 Global Circular RNA Sequencing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Circular RNA Sequencing Sales Value, by Type (2019-2030)
3.2.3 Global Circular RNA Sequencing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research & Academic Institutes
4.1.2 Pharma & Biotech Companies
4.1.3 CROs
4.2 Global Circular RNA Sequencing Sales Value by Application
4.2.1 Global Circular RNA Sequencing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Circular RNA Sequencing Sales Value, by Application (2019-2030)
4.2.3 Global Circular RNA Sequencing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Circular RNA Sequencing Sales Value by Region
5.1.1 Global Circular RNA Sequencing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Circular RNA Sequencing Sales Value by Region (2019-2024)
5.1.3 Global Circular RNA Sequencing Sales Value by Region (2025-2030)
5.1.4 Global Circular RNA Sequencing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Circular RNA Sequencing Sales Value, 2019-2030
5.2.2 North America Circular RNA Sequencing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Circular RNA Sequencing Sales Value, 2019-2030
5.3.2 Europe Circular RNA Sequencing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Circular RNA Sequencing Sales Value, 2019-2030
5.4.2 Asia Pacific Circular RNA Sequencing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Circular RNA Sequencing Sales Value, 2019-2030
5.5.2 South America Circular RNA Sequencing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Circular RNA Sequencing Sales Value, 2019-2030
5.6.2 Middle East & Africa Circular RNA Sequencing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Circular RNA Sequencing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Circular RNA Sequencing Sales Value
6.3 United States
6.3.1 United States Circular RNA Sequencing Sales Value, 2019-2030
6.3.2 United States Circular RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Circular RNA Sequencing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Circular RNA Sequencing Sales Value, 2019-2030
6.4.2 Europe Circular RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Circular RNA Sequencing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Circular RNA Sequencing Sales Value, 2019-2030
6.5.2 China Circular RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Circular RNA Sequencing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Circular RNA Sequencing Sales Value, 2019-2030
6.6.2 Japan Circular RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Circular RNA Sequencing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Circular RNA Sequencing Sales Value, 2019-2030
6.7.2 South Korea Circular RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Circular RNA Sequencing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Circular RNA Sequencing Sales Value, 2019-2030
6.8.2 Southeast Asia Circular RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Circular RNA Sequencing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Circular RNA Sequencing Sales Value, 2019-2030
6.9.2 India Circular RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Circular RNA Sequencing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Creative Biogene
7.1.1 Creative Biogene Profile
7.1.2 Creative Biogene Main Business
7.1.3 Creative Biogene Circular RNA Sequencing Products, Services and Solutions
7.1.4 Creative Biogene Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.1.5 Creative Biogene Recent Developments
7.2 Bio Basic Asia Pacific
7.2.1 Bio Basic Asia Pacific Profile
7.2.2 Bio Basic Asia Pacific Main Business
7.2.3 Bio Basic Asia Pacific Circular RNA Sequencing Products, Services and Solutions
7.2.4 Bio Basic Asia Pacific Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.2.5 Bio Basic Asia Pacific Recent Developments
7.3 LC Sciences
7.3.1 LC Sciences Profile
7.3.2 LC Sciences Main Business
7.3.3 LC Sciences Circular RNA Sequencing Products, Services and Solutions
7.3.4 LC Sciences Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.3.5 Eurofins Recent Developments
7.4 Eurofins
7.4.1 Eurofins Profile
7.4.2 Eurofins Main Business
7.4.3 Eurofins Circular RNA Sequencing Products, Services and Solutions
7.4.4 Eurofins Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.4.5 Eurofins Recent Developments
7.5 Illumina
7.5.1 Illumina Profile
7.5.2 Illumina Main Business
7.5.3 Illumina Circular RNA Sequencing Products, Services and Solutions
7.5.4 Illumina Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.5.5 Illumina Recent Developments
7.6 CD Genomics
7.6.1 CD Genomics Profile
7.6.2 CD Genomics Main Business
7.6.3 CD Genomics Circular RNA Sequencing Products, Services and Solutions
7.6.4 CD Genomics Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.6.5 CD Genomics Recent Developments
7.7 Arraystar
7.7.1 Arraystar Profile
7.7.2 Arraystar Main Business
7.7.3 Arraystar Circular RNA Sequencing Products, Services and Solutions
7.7.4 Arraystar Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.7.5 Arraystar Recent Developments
7.8 Guangzhou Kidio Biotechnology Co., Ltd.
7.8.1 Guangzhou Kidio Biotechnology Co., Ltd. Profile
7.8.2 Guangzhou Kidio Biotechnology Co., Ltd. Main Business
7.8.3 Guangzhou Kidio Biotechnology Co., Ltd. Circular RNA Sequencing Products, Services and Solutions
7.8.4 Guangzhou Kidio Biotechnology Co., Ltd. Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.8.5 Guangzhou Kidio Biotechnology Co., Ltd. Recent Developments
7.9 Shanghai Bioegene
7.9.1 Shanghai Bioegene Profile
7.9.2 Shanghai Bioegene Main Business
7.9.3 Shanghai Bioegene Circular RNA Sequencing Products, Services and Solutions
7.9.4 Shanghai Bioegene Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.9.5 Shanghai Bioegene Recent Developments
7.10 Yanzai Biotechnology (Shanghai) Co., Ltd
7.10.1 Yanzai Biotechnology (Shanghai) Co., Ltd Profile
7.10.2 Yanzai Biotechnology (Shanghai) Co., Ltd Main Business
7.10.3 Yanzai Biotechnology (Shanghai) Co., Ltd Circular RNA Sequencing Products, Services and Solutions
7.10.4 Yanzai Biotechnology (Shanghai) Co., Ltd Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.10.5 Yanzai Biotechnology (Shanghai) Co., Ltd Recent Developments
7.11 Digital Spectrum (Shanghai) Biotechnology Co., Ltd
7.11.1 Digital Spectrum (Shanghai) Biotechnology Co., Ltd Profile
7.11.2 Digital Spectrum (Shanghai) Biotechnology Co., Ltd Main Business
7.11.3 Digital Spectrum (Shanghai) Biotechnology Co., Ltd Circular RNA Sequencing Products, Services and Solutions
7.11.4 Digital Spectrum (Shanghai) Biotechnology Co., Ltd Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.11.5 Digital Spectrum (Shanghai) Biotechnology Co., Ltd Recent Developments
7.12 Guangzhou Codon Gene Technology Co., Ltd
7.12.1 Guangzhou Codon Gene Technology Co., Ltd Profile
7.12.2 Guangzhou Codon Gene Technology Co., Ltd Main Business
7.12.3 Guangzhou Codon Gene Technology Co., Ltd Circular RNA Sequencing Products, Services and Solutions
7.12.4 Guangzhou Codon Gene Technology Co., Ltd Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.12.5 Guangzhou Codon Gene Technology Co., Ltd Recent Developments
7.13 Shanghai Biotechnology Corporation
7.13.1 Shanghai Biotechnology Corporation Profile
7.13.2 Shanghai Biotechnology Corporation Main Business
7.13.3 Shanghai Biotechnology Corporation Circular RNA Sequencing Products, Services and Solutions
7.13.4 Shanghai Biotechnology Corporation Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.13.5 Shanghai Biotechnology Corporation Recent Developments
7.14 Beijing Abace Biology
7.14.1 Beijing Abace Biology Profile
7.14.2 Beijing Abace Biology Main Business
7.14.3 Beijing Abace Biology Circular RNA Sequencing Products, Services and Solutions
7.14.4 Beijing Abace Biology Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.14.5 Beijing Abace Biology Recent Developments
7.15 BGI TechSolutions Co.,Ltd. (BGI-Tech)
7.15.1 BGI TechSolutions Co.,Ltd. (BGI-Tech) Profile
7.15.2 BGI TechSolutions Co.,Ltd. (BGI-Tech) Main Business
7.15.3 BGI TechSolutions Co.,Ltd. (BGI-Tech) Circular RNA Sequencing Products, Services and Solutions
7.15.4 BGI TechSolutions Co.,Ltd. (BGI-Tech) Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.15.5 BGI TechSolutions Co.,Ltd. (BGI-Tech) Recent Developments
7.16 Shanghai Cloudseq
7.16.1 Shanghai Cloudseq Profile
7.16.2 Shanghai Cloudseq Main Business
7.16.3 Shanghai Cloudseq Circular RNA Sequencing Products, Services and Solutions
7.16.4 Shanghai Cloudseq Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.16.5 Shanghai Cloudseq Recent Developments
7.17 Wuhan Benagen Technology Company Limited
7.17.1 Wuhan Benagen Technology Company Limited Profile
7.17.2 Wuhan Benagen Technology Company Limited Main Business
7.17.3 Wuhan Benagen Technology Company Limited Circular RNA Sequencing Products, Services and Solutions
7.17.4 Wuhan Benagen Technology Company Limited Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.17.5 Wuhan Benagen Technology Company Limited Recent Developments
7.18 Hangzhou Lianchuan Biological Information Co.,Ltd.
7.18.1 Hangzhou Lianchuan Biological Information Co.,Ltd. Profile
7.18.2 Hangzhou Lianchuan Biological Information Co.,Ltd. Main Business
7.18.3 Hangzhou Lianchuan Biological Information Co.,Ltd. Circular RNA Sequencing Products, Services and Solutions
7.18.4 Hangzhou Lianchuan Biological Information Co.,Ltd. Circular RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.18.5 Hangzhou Lianchuan Biological Information Co.,Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Circular RNA Sequencing Industrial Chain
8.2 Circular RNA Sequencing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Circular RNA Sequencing Sales Model
8.5.2 Sales Channel
8.5.3 Circular RNA Sequencing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Creative Biogene
Bio Basic Asia Pacific
LC Sciences
Eurofins
Illumina
CD Genomics
Arraystar
Guangzhou Kidio Biotechnology Co., Ltd.
Shanghai Bioegene
Yanzai Biotechnology (Shanghai) Co., Ltd
Digital Spectrum (Shanghai) Biotechnology Co., Ltd
Guangzhou Codon Gene Technology Co., Ltd
Shanghai Biotechnology Corporation
Beijing Abace Biology
BGI TechSolutions Co.,Ltd. (BGI-Tech)
Shanghai Cloudseq
Wuhan Benagen Technology Company Limited
Hangzhou Lianchuan Biological Information Co.,Ltd.
听
听
*If Applicable.
